Document is current
Any future updates will be listed below
-
Authors
Neblett, Michael F. II
Ducharme, Merrick T.
Meridew, Jeffrey A.
Haak, Andrew J.
Girard, Sylvie
Tschumperlin, Daniel J.
Stewart, Elizabeth A. https://orcid.org/0000-0003-1110-2400
-
Funding
Funding for this research was provided by:
Mayo Clinic Center for Biomedical Discovery
Mayo Clinic Department of OB/GYN
- License Information
-
More Information
Article History
Received: 10 September 2024
Accepted: 17 December 2024
First Online: 29 December 2024
Declarations
: EAS has received grants for her institution from the Agency for Healthcare Research and Quality/Patient-Centered Outcome Research (P50HS23418), and the Eunice Kennedy Shriver Institute of Child Health and Human Development of the National Institutes of Health (R01HD105714, R01HD109127-01A1 and P50HD115283); has received consulting fees from AbbVie, Anylyn; support for service on a DSMB from Myovant, holds a patent for Methods and Compounds for Treatment of Abnormal Uterine Bleeding; has received royalties from UpToDate; has received fees for developing educational content from the MED-IQ, Physicians’ Education Resource, Omnia Education, Omnicuris and WebMD; and serves as an unpaid advisor to The Fibroid Foundation and the unpaid treasurer of the International Gynecologic Society. The remaining authors report no conflict of interest.
